Launching our “Gene of the Week” series

Every day, scientists are using BioGPS to get additional information about the genes they are interested in: expression patterns, biological pathways, and more.

We have lots of data on which genes you have been using BioGPS to learn more about, and in the coming months we are going to be sharing some of these insights with you. We are launching a series we’re calling “Gene of the Week“, where we’ll give you a glimpse into the genes that our users are interested in.  How will it work? Each week, we’ll hand pick a gene from recently popular genes in the BioGPS traffic logs  and we’ll be drilling into what makes them interesting, putting them into the context of recent and historical research. We are aiming for unique genes — genes that many us have never heard of, but are timely and important in some area of genomic research.

For our first post, Melissa Lau has a great write-up on HFE and its role in hereditary hemochromatosis:

Armed with leeches, scalpels, and scarificators, medical practitioners (and their patients) once trusted bloodletting as a valid, sensible remedy for common ailments.  In the time before “germs” existed, physicians thought that disease derived from an imbalance of certain bodily fluids—including blood.  Today, belief in this theory of “body humors”, and the consequent use of bloodletting as a restorative cure-all (Got a headache?  Put a leech on it!), is largely dismissed as an ill-conceived, archaic practice.  Even so, early doctors weren’t totally wrong; bloodletting is still considered a legitimate medical treatment for specific conditions—most notably, hemochromatosis.

Read “HFE and Modern-Day Bloodletting


0 Comments

Trackbacks/Pingbacks

  1. HFE and Modern-Day Bloodletting | The Su Lab - [...] Editor’s note: This post is the first in out “Gene of the Week” series. Learn more about it here.…

Leave a Reply

Your email address will not be published. Required fields are marked *